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Interaction between Cadmium and
Selenium in Rat Plasma
by T. A. Gasiewicz*t and J. C. Smith*
The metabolism of75Se-labeled SeO32- and its conversion by intact rat erythrocytes in vitro to a form
which complexes with Cd and plasma proteins were studied. By utilizing both excess SeO32- and N-
ethylmaleimide to lower erythrocyte reduced glutathione (GSH) concentrations, it was shown that the
uptake and metabolism of SeO32- were GSH-dependent, the probable intermediate being glutathione
selenotrisulfide (GSSeSG). Secondary release of selenium by rat erythrocytes had no relation to the
erythrocyte transport ofoxidized glutathione (GSSG). While fluoride depressed and chromate increased
GSSG transport, chromate, a glutathione reductase inhibitor, decreased selenium release. This release
appeared to be secondary to a reaction catalyzed by glutathione reductase. The similarity of150 values for
chromate's inhibition ofglutathione reductase and for the inhibition ofselenium release further suggested
a relationship between these two events. H2Se or a similar product ofGSSeSG reduction is proposed to be
the active product of SeO32- metabolism by rat erythrocytes. By use of gel-filtration and ion-exchange
methods it was noted that the incubation of H2Se with cadmium and plasma produced a Cd-Se complex
indistinguishable from that produced by incubation ofCd, SeO32-, plasma, and erythrocytes in vitro, or
that noted following the administration of Cd and SeO3 in vivo. A mechanism whereby the tissue
distribution and toxicity of cadmium are altered by selenium is suggested.
Introduction
Following the observation of Kar, Das, and
Mukeri (1) that the testicular lesions produced by
cadmium could be prevented by the administration
of selenium compounds, a number of workers have
demonstrated the protective action of selenium
compounds, especially of selenite (Seo32-), on
many of the biological effects of cadmium. The re-
versal of selenium toxicity by cadmium has also
been demonstrated (2).
Although selenium completely protected against
cadmium-induced testicular damage in rats, the
uptake of cadmium by testicular tissue was in-
creased (3). This suggested that selenium diverted
cadmium from its usual target in the testes. Cad-
mium concentrations in other tissues were also al-
tered, but the most pronounced change was in
plasma, which showed a 30- to 50-fold increase in
cadmium levels over control (4, 5). The distribution
of cadmium in the soluble proteins of tissues was
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also altered by selenium (6, 7), and a Cd-Se-
containing moiety appeared which moved at the
void volume of G-75. The Cd-Se-containing frac-
tions of plasma were of higher molecular weight.
Some preliminary data on the interaction of cad-
mium and selenium have been presented previously
by the present authors (8). This paper provides
more details on these interactions.
Cadmium and selenium given to rats simultane-
ously increased the plasma levels of both over the
levels seen when each was given alone. The peak
level is seen to be attained at 4 hr. The cadmium and
selenium are bound to plasma proteins with an
atomic ratio ofapproximately 1. Initially two peaks
of 130,000daltons and 330,000 daltons are seen. The
lower molecular weight peak is at a maximum at 1
hr and declines thereafter with the concomitant
appearance of a 420,000 dalton peak. The latter
peak is at a maximum at 12 hr. The 300,000 dalton
peak appears to persist for the 24-hr time period
studied.
Results and Discussion
The Cd-Se complex did not form when Cd and
SeO32- were incubated with plasma in vitro. Upon
August 1978 133incubation of cadmium and selenium with plasma
and washed red cells, the plasma profile showed a
single peak containing equimolar amounts of cad-
mium and selenium and a molecular weight of
130,000.
When SeO32- was incubated with plasma and red
cells, selenium was very rapidly taken up by the red
cells and then released over the course of a few
minutes into the plasma, presumably in the form of
a metabolite. The time course of this process for a
number of starting concentrations of selenium is
shown in Figure 1. While the release is almost com-
plete at low concentrations ofSeO32- (0.5 nmole/ml
erythrocytes), this is not so at high concentrations
(0.5 ,mole/ml erythrocytes). One limiting factor for
the release was the availability of binding sites in
the plasma. Very little selenium was released when
2.5 x 10-7 mole of SeO32- was incubated with 1 ml
of red cells in phosphate-saline buffer, pH 7.4. The
selenium released increased from 30%o at equal vol-
umes of red cells and plasma to 90o at a 7-fold
excess of plasma over red cells.
The uptake, subsequent metabolism, and re-
lease of selenium by rat erythrocytes were depen-
dent on the presence ofreduced glutathione (Fig. 2).
As the concentration of SeO2- in the preparation
was increased, there was a depletion oferythrocyte
GSH, and the amount ofSe released into the plasma
decreased in parallel. However, at higher SeO3
concentrations, above the concentration necessary
for complete depletion ofthe red cell GSH, the pro-
portion of selenium in the plasma rose. This plasma
selenium was largely in the form ofSeO2-, showing
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FIGURE 1. Kinetics of Se release by rat erythrocytes in vitro at
initial SeO32- concentrations of: (A) 5 x 10-10 mole; (B) 5 x
10-i mole; (C) 5 x 10-# mole; (D) 2.5 x 10-7 mole; (E) 5 x
10-7 mole; (F) 5 x 10-6 mole/ml oferythrocytes. Preparations
of 0.2 ml washed rat erythrocytes plus 0.2 ml rat plasma
(14mM glucose) were incubated for 15 min at 37°C priorto the
addition of SeO2- At the appropriate times the exchange of
selenium between erythrocytes and plasma was rapidly ter-
minated by the addition ofdi-I-butylphthalate and immediate
centrifugation at 1600g for 15 min.
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FIGURE 2. The depletion oferythrocyte GSH by increasing con-
centrations ofSe02-and the corresponding distribution ofSe
at 30 min. Preparations consisted of0.4 ml erythrocytes plus
0.4 ml plasma (14mM glucose). Incubation was for 15 min at
37°C prior to the addition of SeO2-. After an additional 30
min incubation and centrifugation, 0.1 ml of packed erythro-
cytes was taken for GSH analysis. Each point is the mean of
two determinations.
that metabolism had not taken place. Similar results
were obtained when N-ethylmaleimide was used to
deplete erythrocyte GSH. It seems likely that
SeO 2- follows the reductive metabolism, as pro-
posed by Ganther (9) and shown in Eq. (1)
H2SeO3 + 4SGH -. GSSeSG + GSSG + 3H20 (1)
Sandholm (10) postulated that selenium was re-
leased from erythrocytes as a glutathione complex.
Jenkins and Hidiroglou (11) suggested that most of
the selenium released from bovine erythrocytes in
vitro was in the form of GSSeSG. It was proposed
that the mechanism of release was similar to the
transport of GSSG.
Our conclusion is that the release of selenium is
not related to the release ofGSSG and that the form
of selenium released is not GSSeSG.
Fluoride ion, an inhibitor of GSSG release, had
no effect on selenium release from erythrocytes.
However, chromate, an inhibitor of glutathione re-
ductase (12, 13), while increasing the GSSG levels
of both plasma and red cells, can bring about com-
plete inhibition of selenium release from red cells
(Fig. 3).
Within erythrocytes GSSG is normally main-
tained at very low levels by reduction by
glutathione reductase and NADPH (14). Release of
GSSG from erythrocytes could only be demon-
strated when glucose or another source of reducing
equivalents was withdrawn orglutathione reductase
was inhibited by chromate (13). In cell-free prepa-
rations GSSeSG has been found to be a good sub-
strate for yeast glutathione reductase (15), leading
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FIGURE 3. Release of Se from erythrocytes at 1 hr with various
chromate concentrations. Washed erythrocytes (0.2 ml) plus
1.0 ml plasma (14mM glucose) were incubated 10 min at 37°C
prior to the addition of the chromate. At 1 hr 1.0 ml of di-l-
butylphthalate was added for the separation of erythrocytes
and plasma. Each point represents the mean offour determi-
nations; SD's are shown.
to the reduction of selenium to the -2 oxidation
state as H2Se or a similar selenide compound. It
seems likely, therefore, that under physiological
conditions GSSeSG would be further reduced by
glutathione reductase. The similarity between the
150 values for chromate inhibition ofglutathione re-
ductase and inhibition ofselenium release (0.35 and
0.25 ,umole of chromate/pml of erythrocytes, re-
spectively) may also suggest that selenium metab-
olism is linked to glutathione reductase.
As noted above, SeO2- did not produce a com-
plex with cadmium when incubated with plasma in
the absence of erythrocytes. Neither did GSSeSG
incubated with plasma. However, bubbling H2Se
[generated by the method of Diplock et al. (16)]
produced a single Cd-Se peak withan atomic ratio 1
and a molecular weight 130,000. This peak is indis-
tinguishable from that produced by incubating Cd,
Se02-, plasma, and erythrocytes. It is also indistin-
guishable from the lower molecular weight peak
seen in rat plasma following administration of Cd
and SeO3 in vivo, which is the predominant form
of the Cd-Se complex shortly after administration.
If these three peaks were applied separately to
QAE A-50 ion-exchange columns, each was eluted
at the same portion of the gradient (Fig. 4). The
Cd-Se complex was not associated with a major
protein peak and had a charge density slightly less
negative than albumin. The complex was apparently
stable under the conditions of chromatography,
which was carried out at pH 6.5.
When the G-150 gel chromatography was carried
out at pH 6.5 instead of at pH 8 as previously, the
Cd-Se complex formed by bubbling H2Se into
August 1978
0..
0.
0.:
0.
E 0.4
Ic
< O
W
Z 0.
0.;
4-
3- 4.
2-'2 . .3
.1- I..
\ .,
20 40 60 80 100
FRACTION NUMBER
120
.0
.0
13
h2 '
i
FIGURE 4. Sephadex QAE A-50 ion exchange chromatography of
plasma: (A) 1.5 x 10-7 mole H2Se bubbled into 2.0 ml plasma
containing 1 x 10-7 mole Cd; (B) 1 x 10-7 mole Se02- added
to a preparation containing 1.5 ml washed erythrocytes plus
1.6 ml plasma and 1 x 10-7 mole Cd, incubation for 1 hr at
37°C; (C) plasma from a rat injected subcutaneously with 20.0
,umole SeO2-/kg and 20.0 Amole Cd/kg 1 hr before sacrifice.
Ionic strength gradient shown same for (A), (B), and (C). The
volume of whole plasma was 1.0 ml. Column dimensions
were 1.6 x 24 cm. Starting buffer was O.1M Tris-HCI, pH
6.5. Limiting buffer was 0.4M Tris-HCI, pH 6.5. Flow of
buffer was 24.5 ml/hr. Fractions of 2.45 ml were collected.
plasma containing cadmium or by incubating SeO3
with cadmium, plasma, and erythrocytes showed a
molecular weight of 330,000. A similar pattern of
Cd-Se distribution was found following the chro-
matography of plasma from rats injected with Cd
and SeO2- 1, 12, or 24 hr before sacrifice. These
results were taken as evidence that the Cd-Se com-
plex formed under these conditions in vitro was the
same as formed in vivo. The metabolic path from
SeO2- to H2Se has been documented by Ganther
(15) and Hsieh and Ganther (17). This mechanism
seems to exist both in vitro and in vivo, and seems
to be the one whereby the tissue distribution of
cadmium is altered and its toxicity reduced.
Only the 130,000 dalton form is produced by
SeO2- in the presence oferythrocytes and by H2Se
in their absence. The aggregation may be demon-
strated by reducing the pH from 8.0 to 6.5 in gel
chromatography.
Whether this or a similar complex is formed in
compartments other than plasma is not known. Ifit
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0is, then alarge proportion ofthe cadmium dose may
be sequestered in this manner. At 4-5 hr after
simultaneous selenium and cadmium administration
as much as 20%o of the dose is in the form of the
complex in plasma alone.
Because of the rapid metabolism of selenium in
vivo and by erythrocytes in vitro the complex will
only be formed if the selenium is not given too far
ahead of the cadmium. The efficacy of SeO2- in
protecting against cadmium toxicity is much greater
than that ofSeO2- and the seleno amino acids. Pre-
sumably these compounds must first be converted
to SeO2-or traverse an alternate pathway to H2Se.
The fate of the Cd-Se complex has not been
studied. The amount ofthe complex is about halfits
peakvalue at 24 hr. The excretion ofcadmium is not
significantly increased (18) and cadmium inhibits
the urinary excretion of selenium, although six
times as much selenium as cadmium appears in the
excreta at 48 hr. The cadmium may deposit slowly
in other tissues as the complex is decomposed. The
liver burden of cadmium is less when selenium is
given simultaneously so that other tissues must
have higher levels. The slow rate of release ofcad-
mium may allow secondary protection such as is
afforded by the synthesis of metallothionein.
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